Boehm-Viswanathan, T <br/><br/>
Is angiogenesis inhibition the Holy Grail of cancer therapy?  [electronic resource] 

 -  Current opinion in oncology  Jan 2000 
 - 89-94 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1040-8746 
<br/><br/><label>Standard No.: </label>10.1097/00001622-200001000-00015  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--pharmacology<br/>Cell Transformation, Neoplastic<br/>Endothelial Growth Factors--metabolism<br/>Humans<br/>Hypoxia<br/>Lymphokines--metabolism<br/>Neoplasms--blood supply<br/>Neovascularization, Pathologic--physiopathology<br/>Vascular Endothelial Growth Factor A<br/>Vascular Endothelial Growth Factors